Elite Pharmaceuticals Inc (QB) (ELTP) News

Hi barttrab11, thanks for the update. CVS uses Cardinal as their primary wholesaler. Perhaps you will get Elite brand next time.

His adrenaline level is so high by losing his only argument that he can’t think.


I simply destroyed the mikah tax by reading the document until the end.

He can’t compute

My what a bossy demanding little troll you are.

This was my favorite part of the cc:
"Elite is positioned as an attractive generic pharmaceutical company with consistent profits, steady (income?) and low debt. Our fundamentals are strong. We are in the best financial position that we have ever been in. We have always targeted a merger or acquisition as our end point...we believe now is the time for a merger or acquisition or to be uplisted to NASDAQ.  We have been working quietly very hard on this issue ."
You know what would be great? Seeing this PR before the Percocet launch. 😀 Perhaps a very slim chance, but nothing would make me happier. 

Interesting read. Throw in a 90,000 SQ FT manufacturing and packing campus that's for sale during the current climate and wow! IMO this is a once in a lifetime opportunity! Good luck everyone!

https://www.drugpatentwatch.com/blog/mergers-and-acquisitions-opportunities-and-challenges-in-generic-drug-development/?srsltid=AfmBOorhPbdRymlQABPD7-Gew3yEV40db9jaj-oWPh9VumH-Uj4mTif-

Hi James,
My son filled his Vyvanse script last week. The first CVS didn’t have any generic, but they redirected him to a nearby CVS which had the generic. So the shortage seems to be lessening to me.

No rumors, the buyout talk came directly from the CEO . Elite is for sale.

GLTY

If I recall, you said you made a million or more back at .15, so if you really bought back, why not give away your shares for free like you think Nasrat should do.

Good thing you’re selling all your bridges. Rumor has it that Trump is putting a 1000% tariff on them even if made locally. RFK will likely ban Kool-Aide.

Guess you better buy ELTP so you’re not completely broke.

It is baffling why investors are letting go of their shares at the lower bid prices. Elite has so many pending positive press releases coming out soon. Elite is a very well run company and has been cash flow positive for the past 5+ years. 
It is about to be acquired, merged with another pharmaceuticals company, or up-listed on the NASDAQ.
Good luck to all of you Long investors out there . 
Share this information with all your family members, friends, and peers to help them get richer also.


Here are some receipts of their great accomplishments so far.


1. Methotrexate launched on 8/27/24 
~ $63 Million market


https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Generic-Methotrexate-Sodium-8-27-2024




2. Codeine with acetaminophen launched on 10/7/24 
~ $47 Million market


https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Acetaminophen-and-Codeine-Phosphate-Tablets-10-7-2024




3. Hydrocodone with acetaminophen launched on 12/2/24 
~ $300 Million market


https://elite.irpass.com/irpass.asp?ResLibraryID=140659&BzID=2258&L=1&s=0&G=939&Nav=0




4. Generic Vyvanse launched on 12/26/24 
~ $4.3 Billion martket


https://elite.irpass.com/irpass.asp?ResLibraryID=141273&BzID=2258&L=1&s=0&G=939&Nav=0


5. Elite Pharmaceuticals, Inc. Announces First Shipment Of Product From New Facility And Packaging Line


https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=143102&BzID=2258&g=939&Nav=0&LangID=1&s=0


6. Opioid Abuse Deterrent Technology
https://elitepharma.com/technology-overview/


Many catalysts are on deck to fuel ELTP to rocket up again.


1. Launch of generic Percocet
~ $500 million market


2. Launch of generic Dolophine (methadone)  
~ $30 million market


3. Pending acquisition and merger news


4. Pending generic Adderall IR launch in Israel


5.  Pending positive ruling for Elite with generic OxyContin
~ $700 Million market


6. Record breaking quarterly revenue report on  6/30/25


7. April 1 - Elite terminates Prasco Agreement and begins marketing Adderall XR 100% by themselves


8. Tariffs begin - wild card for merger/acquisition, most likely to  contribute an added premium to our acquisition price


Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat


https://www.cnbc.com/amp/2025/02/26/eli-lilly-to-invest-27-billion-in-new-us-manufacturing.html


J&J boosts US investments by 25% over 4 years amid looming tariff threats | Reuters


https://www.cnbc.com/amp/2025/03/21/jj-boosts-investments-in-us-to-more-than-55-billion-amid-looming-tariff-threats-.html


9. Pending Dopamine Agonist approval


10. Pending India R&D Agreement signed


11. Pending Positive BE studies (Concerta and Undisclosed)
~ $1.2 Billion market


https://fullratio.com/pe-ratio-by-industry


Share Price = EPS x P/E Ratio
$0.2172 = $.01 x 21.72
$0.4344 = $.02 x 21.72
$0.6516 = $.03 x 21.72
$0.8688 = $.04 x 21.72
$1.0860 = $.05 x 21.72
$1.3032 = $.06 x 21.72
$1.5204 = $.07 x 21.72
$1.7376 = $.08 x 21.72
$1.9548 = $.09 x 21.72
$2.1720 = $.10 x 21.72


Elite Pharmaceuticals was listed in all 4 recent articles with Apple stock app.


February 2025 Penny Stocks To Keep An Eye On


https://stocks.apple.com/Ah9N4nOg_ShisgYYtddapjQ


3 Promising Penny Stocks Below $500M Market Cap


https://stocks.apple.com/AFW8crl7LSt-kNf2QgI1BYA


US Penny Stocks To Watch In November


2024https://stocks.apple.com/A_kvAJIyeQ7SiwuErhr-tyQ


3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap


https://stocks.apple.com/AQxaED0BeSTqmWev2Z85VvQ

I’m not to worried about RFK and Adderall,
Too many helicopter parents want their kids on stimulants
It helps them get better grades
When they get get better grades they go to better colleges
When they get a better higher education, they get a better job.
The competition is stiff out there.

I sense your agony, must be that pressure coming from the PuppetMaster.

He also described the foods in the US are "just poison". 8b

Not feeling good about idiot Kennedy. He’s going to sink us

Abort. Red flags. Sub 12 cents is near. Volume is drying up. The buyout rumors are slowly getting less and less. The tax has been discussed and uncovered to be more than originally thought. Typical otc play, from start to now a slow ending. Rfk won't be the death, it's the rumors and bridge buyers who drank the Kool aide are the ones to bury this dead dream. But don't worry, buyout is coming in July of 2028 now. And at $3. Bridges are almost done, who wants?

If the number of shares is capped at 4.99% of the float, he will get 53 Million shares vs 79 million shares.

It is arithmetic's.

Bravo !!!!!!

Prove it

Its written in black on white.

Less Mikah tariffs? lol

RFK jr just stated in a press conference that Adeerall is a poison That won’t help us.

Percoset is already approved. Just waiting to launch it ANY day .

ELTP

There are reports biotech sector being negatively affected by ee cuts at FDA creating a lot of uncertainty along with delays for things such as approvals...hence why nothing yet on Percocet approval...???

This is false.

Just want to mention that the maximum number of shares the warrants can be translated to is 4.99% of the float or about 53.2 Million shares.

Why doesn’t Nasrat just give MIKAH to elite. He’s made enough. Also, the warrants, just forfeit those. Again, he’s made enough. Do something for the damn shareholders, not just the hakim family. Just my opinion

If you ask the Link for the 4.99%, it is in the document shared by Jour earlier today.

The second part was a Grok output based on the prompt I developed for it and asking to attribute the Warrants to that document and NOT the 2013-2016 Lincoln Financial period.

Red flags. Red flags. Abort. Volume is decreasing. Stories are drying up. Bridges are almost ready.

I missed the keyword "REPEAL" by getting rid of Micah.

Link?

You've been advocating the mikah tax for so long, why not bombard Elite management with email or better yet a letter addressed to Nasrat and see what happens.

I have no idea what you're trying to ask here, but I do believe that you tried your best. Bless your heart.

.

Just want to mention that the maximum number of shares the warrants can be translated to is 4.99% of the float or about 53.2 Million shares.

------
Assuming the 79 million warrants originate solely from the 2017 Series J conversion, they pose a dilution risk if exercised, given the attractive $0.1521 exercise price versus the $0.409 stock price. However, ownership limits, potential shareholder approval delays, and ELTP’s strong financials (e.g., $32 million working capital surplus) mitigate concerns. Ward’s emphasis on non-cash liabilities and operational strength suggests investors should focus on ELTP’s growth trajectory, though vigilance on warrant developments is advised.

James is an asset to this board and post very informative information, BUT he can't "Repeal the Mikah Tax" !!!!!!!!!!!!!!!!!!

How do you propose to move nasrat into "Repealing the Mikah Tax" and putting shareholders interest FIRST ??????????

Hummmmm,

IB_🤴

You've been advocating the mikah tax for so long, why not bombard Elite management with email or better yet a letter addressed to Nasrat and see what happens.

If Mikah is sold to a public company there can be no secret Mikah check.

You are correct, JamesF1, and this is precisely what I mean by Second Tier Suitors as a major component of the Mikah Tax. The top public companies will take a pass as soon as they hear about Mikah. There will be no top tier offers because none of them will want to involve themselves with this oddball CEO or his private company. Negotiations will be with second tier suitors from nonpublic entities who will have no qualms about making a lucrative secret side deal for Mikah while getting a nice discount for public Elite. As long as Mikah exists, it will be Hakim #1 and shareholders not.

I will also point out, JamesF1, that Elite is a public company, and as you say, if Mikah is sold to Elite (again!) then there can be no secret Mikah check. The only hope for any kind of transparency for Elite shareholders is if Mikah is dealt with BEFORE the buyout. He could announce the deal and hold a vote from which he is recused. Why not deal with Mikah in a transparent way? Who benefits from a secret deal? Elite does not need Mikah, but Mikah is nothing without Elite. It's time to get rid of Mikah forever. Repeal the Mikah Tax.

.

Good Morning, James

Can I count on your support ????????????

IB_🤴

GM IB_, if you want to run for a spot on Elite’s board of directors no one is stopping you.

If Mikah is sold to a public company there can be no secret Mikah check.

I agree ...........

Now, what do you propose that we do to persuade nasrat to put ALL shareholders interest, First ?????????????

IB_🤴

This is the meat of the matter:

...But you look at what is in the total liabilities and there's one thing that jumps out at you and it's the derivative liability for the warrants. That increase that went from 9 to 22,000,000.

... I've mentioned this before, but the derivative liabilities are related to the warrants and they're valued using the Black Scholes method and they essentially the level of liability varies directly with our stock price. If the price goes up, the price per share goes up, the liability goes up. If the price per share goes down, the liability goes down.

...So first of all, it's not possible to remove the warrants from the financials as GAAP requires that we account for them and we present them as we are presenting them. So the balance sheet, the cash flow, the P and L statement, they all have to take into consideration the warrants and it can't be excluded.


The CFO tends to meander and muddle the message, but the gist is simple. As our share price increases, so do the liabilities for Hakim's warrants, which drags down the net income. The benefits of net income that should accrue to shareholders are cancelled out by the warrant liabilities, and that includes market value and ultimate buyout price. I predict the depressed income numbers will be just one of the excuses for a disappointing buyout price; meanwhile, Hakim will deposit that secret Mikah check at his private bank.

The CFO is wrong to say there is no way to remove the warrants from the financials. There is a very obvious way-- once Hakim exercises the warrants then they immediately disappear as an ongoing liability for the rest of Elite shareholders. He doesn't have to put up any cash, but he does have to exchange shares. The longer he waits, the fewer shares he will need to forfeit. Again and again and again it's Hakim #1 and Elite shareholders somewhere down the list.

.

L2 strongly suggests that if we got some good news now, this would pop again nicely.

Thanks Green Weezuhl

Take Action !!!!!!!!!!!!!!!!!!!!!

What are your/our options for change ????????????

Arguing on this board will accomplish nothing .................


Elite needs a complete overhaul of the Board of Directors but there will be "0" changes unless someone other than Elite's current management makes them,

IB_🤴

This is not AI - This is the CFO on record:

Explain the variance in liabilities since the June quarter. So total liabilities in June were 29.6 and the total liabilities in September were 40.9. So that's $11,000,000 increase. But you look at what is in the total liabilities and there's one thing that jumps out at you and it's the derivative liability for the warrants. That increase that went from 9 to 22,000,000.

So that increased by almost $13,000,000 So while my total liabilities increased by $11,000,000 the derivative component of that increased by $13,000,000 So if you take that out, the overall liabilities actually went down. And let me just say one thing on the derivatives. I've mentioned this before, but the derivative liabilities are related to the warrants and they're valued using the Black Scholes method and they essentially the level of liability varies directly with our stock price. If the price goes up, the price per share goes up, the liability goes up. If the price per share goes down, the liability goes down.

In June, our stock price was $19,900,000 in September, our stock price was $38,800,000 it almost doubled over this quarter. Now we're I don't know where we are right now, but around $0.50. So thank you everybody for bringing our stock price up. One of the effects is because of the calculation, the liability goes up. But always keep in mind when you see this liability, it is a noncash item.

There will never ever, ever be cash involved with this liability, just something that we record, to comply with GAAP. So instead of looking at the total liabilities, I really focus more on the ratio between liabilities and assets, especially the the working capital of the current liability. Current liabilities as compared to current assets, That's all working capital. That's my main area of focus. We have large investments as you'll see in inventory and receivables.

Generally, as those increase, you're also going to see an increase in accounts payable and accrued liabilities. They kind of track with each other. The important thing is you always want to have more on the asset side than the liability side. That's a surplus. That's your working capital.

The larger the surplus, the better it is. The more liquid we are, the stronger our balance sheet is. And we have a $32,000,000 surplus as of September 30, and that surplus grew by more than $5,000,000 this quarter alone. So, that's the metric I'm most focused on with regards to liabilities and it does show our balance sheet is strengthening. I think I have one other question on the warrant liability or the warrants in general and that was related to asking are we going to shift to an adjusted EBITDA disclosure reporting with that excluding the warrant impact on EBITDA.

So first of all, it's not possible to remove the warrants from the financials as GAAP requires that we account for them and we present them as we are presenting them. So the balance sheet, the cash flow, the P and L statement, they all have to take into consideration the warrants and it can't be excluded. But what you're referring to with an adjusted EBITDA is really, what's known as a non GAAP financial measure and that would have to be presented in footnote manner and not part of the core four financial statements, something separate in the footnote, and that's not something we're considering at this time. Everyone I speak to regarding Elite Financials, they evaluate the warrants and their impacts separately depending upon the nature of analysis that they are conducting. So we disclose as per GAAP, the warrants are easily identified and who's ever evaluating our company can either include them or exclude them depending upon the nature of their evaluations.

That's really what happens. So to sum things up, our financials continue on the growth trajectory. Revenues are up, profits are up, working capital is increasing, debt is low, the balance sheet is strengthening, cash flow that we're generating internally is funding future growth, the pipeline is progressing and positioned to maintain an upward trajectory. So all in all, it was quite a good quarter.

I think you should sell them if you feel sick! It's much higher than when you used to complain at 4 cents!. Take your profit and feel better and get some medicine as long as you are at it.

GLTU

I'll take that as a No I can't answer any of those questions and No I am not capable of having a fact-based discussion with a fellow shareholder who raises legitimate questions about the CEO's constant self-dealing. Pretty much what I expected. Nice to know you're so worried about my share count. I've got plenty of shares, thank you, and I'm pretty sick of holding them while the CEO plays his billionaire games and ignores his fiduciary duty to Elite shareholders.

.

Im buyin' the dips.
THX

I never said Nasrat is infallible. Pot calling the kettle black? Lmao.

The saddest thing about the "I spent all my shares on a used car and I know everything about everything" crowd is that they endlessly bitch for years like a scorned ex-girlfriend. I'm sure I'm wrong because I don't have a PhD or an MD hanging on the wall but I'm pretty sure living life in a state of constant bitterness isn't healthy.

Here's the document you should reference regarding the 79M warrants:
https://www.sec.gov/Archives/edgar/data/1053369/000114420417023318/v465621_ex10-1.htm

Sorry ChatELTP but your whole post is wrong. Now let's see if you can figure out where the warrants really did come from. Also, lol.

So why not answer the questions that I asked instead of a bunch of stupid crap that I have never mentioned?


Ask yourself: as the largest shareholder in Elite, wouldn't it be to Hakim's benefit to clear the 79 million warrants that drag down our net income every time the share price goes up? Why wouldn't he execute these cashless warrants now so they stop being a liability for the rest of us? How did awarding himself 79 million warrants benefit the rest of Elite shareholders? How does their continued existence help anyone but Hakim?


The funniest thing about the Do Your Own Research crowd is how consistently shitty they are at doing research. The saddest thing about the Nasrat Is Infallible crowd is how beta they act towards a guy who has both hands in their pockets.

.

First let's find what are these warrants about?

Final Answer
The 79 million warrants were primarily generated by:

2013 Lincoln Park Agreements: ~35 million warrants (15M in July, 20M in November) at $0.15, tied to $50M stock purchase commitments.
2014-2015 Private Placements: ~20-30 million warrants, issued with stock to investors at $0.10-$0.20.
2016 Amendments/Financings: ~10-15 million warrants, including Lincoln Park extensions.
These financed ELTP’s generic drug development but increased dilution risk. For precise warrant status (e.g., exercised/expired), check ELTP’s latest 10-Q or 8-K on SEC.gov. If you want me to pull specific filings or analyze ELTP’s current financials, let me know!